We are live on ! Find out more
T. Rowe Price Investment Management

T. Rowe Price Investment Management Portfolio holdings

AUM $145B
1-Year Est. Return 22.78%
 

T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.

This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+22.78%
3 Year Est. Return
+69.87%
5 Year Est. Return
10 Year Est. Return
AUM
$158B
AUM Growth
-$5.16B
Cap. Flow
-$7.02B
Cap. Flow %
-4.43%
Top 10 Hldgs %
22.66%
Holding
961
New
80
Increased
260
Reduced
443
Closed
63

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$1.18B
2
HOLX
Hologic
HOLX
+$1.14B
3
CI icon
Cigna
CI
+$1.05B
4
ROP icon
Roper Technologies
ROP
+$918M
5
DTE icon
DTE Energy
DTE
+$834M

Sector Composition

Rank Sector Weight
1 Technology 24.82%
2 Healthcare 20.04%
3 Consumer Discretionary 13.58%
4 Financials 12.54%
5 Industrials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACA icon
176
Arcosa
ACA
$7.13B
$182M 0.11%
1,707,884
+342,242
+25% +$34.5M
IRT icon
177
Independence Realty Trust
IRT
$4.02B
$178M 0.11%
10,170,657
-1,731,395
-15% -$28.7M
RVMD icon
178
Revolution Medicines
RVMD
$43.7B
$175M 0.11%
2,200,376
-2,581,942
-54% -$169M
RAL
179
Ralliant Corp
RAL
$7.99B
$174M 0.11%
3,423,268
+563,822
+20% +$26.4M
LOAR icon
180
Loar Holdings
LOAR
$6.82B
$172M 0.11%
2,533,540
+711,182
+39% +$51.9M
HUBS icon
181
HubSpot
HUBS
$10.5B
$172M 0.11%
427,772
-1,886
-0.4% -$781K
CRSP icon
182
CRISPR Therapeutics
CRSP
$5.19B
$169M 0.11%
3,226,595
-55,989
-2% -$3.35M
MSGS icon
183
Madison Square Garden
MSGS
$10.1B
$168M 0.11%
648,515
+49,412
+8% +$11.2M
CWST icon
184
Casella Waste Systems
CWST
$5.78B
$167M 0.11%
1,707,723
+524
+0% +$48.6K
IP icon
185
International Paper
IP
$21.8B
$165M 0.1%
4,182,365
+153,355
+4% +$6.31M
ALC icon
186
Alcon
ALC
$35.4B
$161M 0.1%
2,037,551
-2,844,898
-58% -$219M
HLNE icon
187
Hamilton Lane
HLNE
$5.71B
$160M 0.1%
1,191,158
-100,899
-8% -$12.7M
FLG
188
Flagstar Bank National Association
FLG
$5.92B
$159M 0.1%
12,651,136
-854,088
-6% -$10.2M
GO icon
189
Grocery Outlet
GO
$1.05B
$159M 0.1%
15,763,945
+5,528,722
+54% +$69.6M
CUBE icon
190
CubeSmart
CUBE
$9.4B
$157M 0.1%
4,344,786
-2,021,589
-32% -$76.8M
SHC icon
191
Sotera Health
SHC
$5.42B
$156M 0.1%
8,864,796
-354,197
-4% -$5.86M
LFUS icon
192
Littelfuse
LFUS
$11.5B
$154M 0.1%
609,966
+225,445
+59% +$57.4M
CLBT icon
193
Cellebrite
CLBT
$2.6B
$154M 0.1%
8,514,894
-1,530,087
-15% -$27.5M
VIAV icon
194
Viavi Solutions
VIAV
$10.6B
$151M 0.1%
8,497,432
-2,731,248
-24% -$44.1M
BRKR icon
195
Bruker
BRKR
$8.92B
$150M 0.09%
3,188,928
-3,190,704
-50% -$135M
ENTG icon
196
Entegris
ENTG
$25.1B
$150M 0.09%
1,775,704
-9,492
-0.5% -$825K
GSHD icon
197
Goosehead Insurance
GSHD
$2.28B
$147M 0.09%
2,002,003
+556,293
+38% +$39.6M
MTDR icon
198
Matador Resources
MTDR
$6.41B
$147M 0.09%
3,465,227
-222,351
-6% -$9.34M
BR icon
199
Broadridge
BR
$19.1B
$147M 0.09%
656,837
-294,968
-31% -$67.3M
SMTC icon
200
Semtech
SMTC
$12.7B
$146M 0.09%
1,987,888
+374,548
+23% +$26.6M

Similar funds

T. Rowe Price Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, T. Rowe Price Investment Management held 961 positions worth $158B, down 3.2% from $164B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

T. Rowe Price Investment Management withdrew a net $7.02B in Q4 2025, closing 63 positions and reducing 443 holdings. Its most notable exit was Bright Horizons, an estimated $240M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Investment Management opened a new position in Keurig Dr Pepper worth $728M.

  • T. Rowe Price Investment Management's largest Q4 2025 buy was Keurig Dr Pepper: 25,978,817 shares worth $728M.
  • T. Rowe Price Investment Management added most to Cencora in Q4 2025, an estimated $1.41B increase.
  • T. Rowe Price Investment Management's biggest Q4 2025 reduction was Danaher, cutting an estimated $1.18B.
  • T. Rowe Price Investment Management fully exited Bright Horizons in Q4 2025, selling an estimated $240M.
  • T. Rowe Price Investment Management's ten largest holdings make up 23% of its $158B portfolio in Q4 2025.
  • T. Rowe Price Investment Management opened 80 new positions and closed 63 in Q4 2025.
  • T. Rowe Price Investment Management's portfolio value fell 3.2% quarter-over-quarter to $158B.

Based on T. Rowe Price Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.